Brian Schwartz - 16 Jun 2022 Form 4 Insider Report for INFINITY PHARMACEUTICALS, INC.

Role: Director
Signature: /s/Seth A. Tasker as attorney-in-fact for Brian Schwartz, M.D.
Issuer symbol: N/A
Transactions as of: 16 Jun 2022
Net transactions value: +$20,994
Form type: 4
Filing time: 16 Jun 2022, 20:32:29 UTC
Previous filing: 16 Jun 2022
Next filing: 03 Jul 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	INFI	Common Stock	Award	$20,994	+30,919		$0.6790^*	30,919	16 Jun 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	INFI	Stock Option(right to buy)	Award	$0	+45,000		$0.000000	45,000	16 Jun 2022	Common Stock	45,000	$0.6790	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Pursuant to the issuer's non-employee director compensation program, the reporting person has elected to receive this grant of shares in lieu of cash as payment of approximately 50% of such person's $42,000 annual retainer for service as a director.
F2	The option vests over a period of one year in equal quarterly installments beginning at the end of the first quarter after the date of grant, provided that the holder continues to serve as a director of the issuer.

Remarks:

Exhibit 24 - Limited Power of Attorney